Purpose To assess the influence of an outdoor program on myopia progression in school children. Methods The prospective interventional school-based study included 373 students aged 6 to 7 years (grade 1 or 2) who were examined annually between 2012 and 2016. Between 2012 and 2013, the children in the study group ( n = 157) performed a 30-minute jogging exercise every school day, while the children in the control school ( n = 216) did not. All children underwent a comprehensive ocular examination, including biometry. Results At 1 year after baseline, axial elongation and progression of myopic refractive error were significantly lower in the study group than in the control group. Study group and control group differed in axial elongation only in the subgroup of children nonmyopic at baseline, while axial elongation in the children myopic at baseline did not differ between both groups. At 1 and 2 years after the outdoor program stopped, increase in axial length was significantly larger in the study group. At 4 years after baseline, study group and control group did not differ significantly in total axial elongation and total change in refractive error. Conclusions An outdoor program of 30 minutes performed every school day for 1 year temporarily reduced myopia progression in schoolchildren nonmyopic at baseline, with a complete rebound effect after the program ended within the 3 following years. Translational Relevance An outdoor program of 30 minutes performed every school day for 1 year temporarily reduced the progression of myopia in schoolchildren nonmyopic at baseline for the period when the program was carried out.
ImportanceThe ongoing pandemic of COVID-19 is still affecting our life, but the effects of lockdown measures on gestational diabetes mellitus (GDM) in pregnant women remain unclear.AimTo investigate the association between COVID-19 lockdown and GDM.Subjects and MethodsMedical records of 140844 pregnant women during 2015-2020 were extracted from 5 hospitals in Guangdong Province, China. Pregnant women who underwent the COVID-19 Level I lockdown (1/23 - 2/24/2020) during pregnancy were defined as the exposed group (N=20472) and pregnant women who underwent the same calendar months during 2015-2019 (1/23 - 2/24) were defined as the unexposed group (N=120372). Subgroup analyses were used to explore the potential susceptible exposure window of COVID-19 lockdown on GDM. Cumulative exposure is quantitatively estimated by assigning different weights to response periods with different exposure intensities. A logistic regression model was used to estimate the association between COVID-19 lockdown exposure and GDM.ResultsThe rates of GDM in the exposed and unexposed groups were 15.2% and 12.4%, respectively. The overall analyses showed positive associations (odds ratio, OR=1.22, 95%CI: 1.17, 1.27) between lockdown exposure and GDM risk in all pregnant women. More pronounced associations were found in women who underwent the COVID-19 lockdown in their first four months of pregnancy, and the adjusted OR values ranged from 1.24 (95%CI: 1.10, 1.39) in women with 5-8 gestational weeks (GWs) to 1.35 (95%CI: 1.20, 1.52) with < 5 GWs. In addition, we found a positive exposure-response association of cumulative lockdown exposure with the risk of GDM.ConclusionsThe COVID-19 lockdown was associated with an increased risk of GDM, and the first four months of pregnancy may be the window for sensitive exposure.
Supplemental Digital Content is Available in the Text. A retrospective study followed up for a mean of 4.9 years showed that progression of myopic maculopathy was detected in 18.9% among highly myopic schoolchildren aged 4 to 17 years.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.